This inventor holds 3 USPTO granted patents. Top assignee: Scios Inc.. Active years: 2000-2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2000-2002
Title: The Innovations of Garrett A Lim
Introduction
Garrett A Lim is an accomplished inventor based in Havertown, PA (US). He has made significant contributions to the field of biomedical research, particularly in the development of assays and reagents for quantifying human B-type natriuretic peptide (hBNP). With a total of 3 patents to his name, Lim's work has the potential to impact clinical diagnostics and patient care.
Latest Patents
One of Lim's latest patents focuses on the development of reagents and assays for the quantification of hBNP in biological fluid samples such as plasma or serum. This invention provides antibodies that are monospecific to specific epitopes comprising the amino acid sequences 5-13, 1-10, and 15-25 of hBNP. These antibodies, along with peptide fragments containing these sequences, can be utilized in assays that may be conducted in either a sandwich format or a competition format. Another patent by Lim also centers on human BNP-specific antibodies, reinforcing his commitment to advancing the understanding and measurement of hBNP in clinical settings.
Career Highlights
Garrett A Lim is currently associated with Scios Inc., where he continues to innovate and develop new technologies. His work has been instrumental in enhancing the accuracy and reliability of diagnostic tests, which are crucial for patient management in various medical conditions.
Collaborations
Lim has collaborated with notable colleagues such as Ronald P Mischak and Jan Marian Scardina, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Garrett A Lim's contributions to the field of biomedical research through his patents and collaborations highlight his role as a significant inventor. His work not only advances scientific knowledge but also has the potential to improve patient outcomes in clinical practice.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile